Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue Sarcomas

Refractory or Relapsed RMS and Soft Tissue Sarcomas Clinical Trial

Official title: Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue Sarcomas

Status Recruiting

Clinical Trial Summary

The purpose of this study is to determine the Everolimus aim response in children and adolescents with refractory or relapsed Rhabdomyosarcoma and other soft tissue sarcomas

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Refractory or Relapsed RMS and Soft Tissue Sarcomas
• Rhabdomyosarcoma
• Sarcoma

• NCT number: NCT01216839
• Study type: Interventional
• Source: Hospital Santa Marcelina
• Contact: Sidnei Epelman, MD
• Phone: +55 11 2522-2472
• Email: pesquisaoncoped@santamarcelina.org
• Status: Recruiting
• Phase: Phase 2
• Start date: March 2011
• Completion date: December 2013